Stay updated on KPT-8602 Safety & Efficacy in Refractory Cancer Clinical Trial
Sign up to get notified when there's something new on the KPT-8602 Safety & Efficacy in Refractory Cancer Clinical Trial page.

Latest updates to the KPT-8602 Safety & Efficacy in Refractory Cancer Clinical Trial page
- ChecktodayNo Change Detected
- Check7 days agoChange DetectedThe web page has been updated from version 2.15.0 to version 2.15.2, indicating a revision in the content.SummaryDifference0.3%
- Check15 days agoNo Change Detected
- Check22 days agoChange DetectedThe page has been updated to reflect a new version, changing from v2.14.4 to v2.15.0.SummaryDifference1.0%
- Check29 days agoChange DetectedThe web page has updated its version from v2.14.3 to v2.14.4, and the date has changed from March 25, 2025, to March 19, 2025.SummaryDifference0.7%
- Check44 days agoChange DetectedThe study of KPT-8602 has been updated to reflect a new completion date of March 19, 2025, while the previous status of 'Active, not recruiting' has been removed.SummaryDifference2%
- Check73 days agoChange DetectedThe page has removed a notice regarding heavy traffic affecting the performance and availability of some NLM-NCBI services and products.SummaryDifference5%
- Check87 days agoChange DetectedThe web page now includes a notice about heavy traffic affecting the performance and availability of some NLM-NCBI services and products, along with contact information for assistance.SummaryDifference6%
Stay in the know with updates to KPT-8602 Safety & Efficacy in Refractory Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the KPT-8602 Safety & Efficacy in Refractory Cancer Clinical Trial page.